KLC2 and glioblastoma: On the other hand, 11 of these antigens (ARFGAP2, SPTAN1, KIDINS220, MRTFA, NSFL1C, PLXNA1, MYH10, KIF5A, KLC2, TUBB2A, ITSN1) were found to be significantly higher expressed in normal tissue, using the ONCODB-GBM expression data.